HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Lacouture Selected Research

Exanthema (Rash)

1/2022Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001.
11/2018Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.
3/2017Advanced Care Provider and Nursing Approach to Assessment and Management of Immunotherapy-Related Dermatologic Adverse Events.
1/2015Incidence and risk of rash to mTOR inhibitors in cancer patients--a meta-analysis of randomized controlled trials.
8/2009Eosinophilic rash secondary to temsirolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Lacouture Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 01/2015
5Exanthema (Rash)
01/2022 - 08/2009
5Breast Neoplasms (Breast Cancer)
01/2018 - 04/2012
3Alopecia (Baldness)
01/2022 - 01/2017
3Renal Cell Carcinoma (Grawitz Tumor)
03/2017 - 08/2009
2Disease Progression
11/2021 - 03/2018
2Paronychia
12/2019 - 11/2018
2Histiocytosis
01/2019 - 02/2016
2Stomatitis
11/2018 - 03/2015
2Pruritus (Itching)
11/2018 - 03/2017
2Dermatitis
11/2018 - 01/2018
2Squamous Cell Carcinoma of Head and Neck
03/2017 - 08/2008
1Thrombocytopenia (Thrombopenia)
01/2022
1Ageusia (Hypogeusia)
01/2022
1Basal Cell Carcinoma (Rodent Ulcer)
01/2022
1Drug Hypersensitivity (Drug Allergy)
01/2022
1Dysgeusia (Parageusia)
01/2022
1Fever (Fevers)
01/2022
1Hypersensitivity (Allergy)
01/2022
1Hypotension (Low Blood Pressure)
01/2022
1Nevus (Nevi)
01/2022
1Spasm (Spasms)
01/2022
1Tachycardia (Tachyarrhythmias)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2022
1Arthralgia (Joint Pain)
01/2022
1Second Primary Neoplasms (Neoplasms, Second)
12/2019
1Benign Migratory Glossitis (Geographic Tongue)
11/2018
1Hyperpigmentation
11/2018
1Pyogenic Granuloma
11/2018
1Eczema
11/2018
1Colorectal Neoplasms (Colorectal Cancer)
08/2018
1Erdheim-Chester Disease
03/2018
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
03/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2017
1Hodgkin Disease (Hodgkin's Disease)
03/2017
1Melanoma (Melanoma, Malignant)
03/2017
1Vitiligo
03/2017
1Carcinoma (Carcinomatosis)
03/2017
1Hepatocellular Carcinoma (Hepatoma)
08/2014
1Necrosis
04/2013
1Neoplasm Metastasis (Metastasis)
11/2009
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2008
1Nephrogenic Fibrosing Dermopathy
01/2008
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2006
1Systemic Mastocytosis
11/2006

Drug/Important Bio-Agent (IBA)

6Phosphotransferases (Kinase)IBA
01/2022 - 08/2009
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 02/2016
3Immune Checkpoint InhibitorsIBA
01/2022 - 03/2017
3ErbB Receptors (EGF Receptor)IBA
11/2018 - 08/2008
3MTOR InhibitorsIBA
11/2018 - 01/2015
3TOR Serine-Threonine KinasesIBA
11/2018 - 01/2015
3temsirolimusFDA Link
03/2015 - 08/2009
2Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 01/2016
2AnthracyclinesIBA
01/2017 - 04/2012
2Sorafenib (BAY 43-9006)FDA Link
02/2016 - 08/2014
2Lapatinib (GW572016)FDA Link
01/2016 - 04/2012
2EverolimusFDA Link
03/2015 - 01/2015
1selpercatinibIBA
01/2022
1HhAntag691IBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1CreatinineIBA
01/2022
1Docetaxel (Taxotere)FDA Link
11/2021
1Povidone-Iodine (Betadine)FDA LinkGeneric
12/2019
1Mitogen-Activated Protein KinasesIBA
01/2019
1cobimetinibIBA
01/2019
1VemurafenibIBA
03/2018
1Mometasone Furoate (Nasonex)FDA LinkGeneric
01/2018
1eucerinIBA
01/2018
1Imiquimod (Aldara)FDA LinkGeneric
11/2017
1NivolumabIBA
03/2017
1IpilimumabIBA
03/2017
1atezolizumabIBA
03/2017
1pembrolizumabIBA
03/2017
1taxaneIBA
01/2017
1Trastuzumab (Herceptin)FDA Link
01/2016
1Enoxaparin (Lovenox)FDA LinkGeneric
04/2013
1130-nm albumin-bound paclitaxelIBA
04/2012
1Sunitinib (Sutent)FDA Link
11/2009
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
08/2009
1Pharmaceutical PreparationsIBA
08/2009
1Cetuximab (Erbitux)FDA Link
08/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2008
1PlatinumIBA
08/2008
1Monoclonal AntibodiesIBA
08/2008
1Tyrosine Kinase InhibitorsIBA
08/2008
1Epidermal Growth Factor (EGF)IBA
08/2008
1GadoliniumIBA
01/2008
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2006
1Imatinib Mesylate (Gleevec)FDA Link
11/2006

Therapy/Procedure

5Therapeutics
01/2022 - 08/2008
3Drug Therapy (Chemotherapy)
11/2021 - 01/2017
3Radiotherapy
01/2018 - 08/2008
2Drug Tapering
03/2017 - 01/2015
1Mohs Surgery (Mohs' Micrographic Surgery)
01/2022
1Immunotherapy
01/2019
1Cryotherapy (Therapy, Cold)
11/2017
1Protective Devices (Safety Device)
01/2017
1Transplantation
08/2014